Keywords: tamro, 1st-qtr, profits, rise, maintains, dominance, nordic
Tamro's 1st-qtr profits rise 34%, maintains 51% dominance of Nordic pharma wholesale market
Article | 13 June 2005
Tamro, the northern European pharmaceutical wholesaler operating in the Nordic countries and Baltic States, says that its first-quarter net sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
